Skip to main content
Caplight Logo









Cryton Biosciences

Cryton Biosciences

Private
Austin, MinnesotaHealthcare & Life Scienceshttps://crytonbio.com/

Last Round

Seed

Aug 1, 2025

Total Funding Raised

$200,000

Company Overview

Cryton Biosciences is a biotechnology company developing a dual-action oral drug designed to starve tumors and prime the immune system to kill cancer by targeting mitochondrial metabolism.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

small molecule therapymitochondrial medicineimmuno-oncologytreatment-resistant cancerimmunometabolismcancer metabolismdual-action therapeuticsolid tumor treatmentmetabolic checkpointT-cell exhaustionpreclinical biotechnologydrug discoverybiotech licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cryton Biosciences Comparables

Compare Cryton Biosciences with similar companies based on industry and business-model similarity.

Cryton Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mito BioPharma
81%
Madera Therapeutics
81%
Imel Biotherapeutics
69%

Cryton Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 1, 2025
AcceleratorAug 1, 2025

Cryton Biosciences Investors

Notable investors and investment history

Cryton Biosciences investors
InvestorRounds
Right Side Capital ManagementSeed, Accelerator
gener8torAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2025

    $100K round led by Right Side Capital Management

  • Aug 1, 2025

    $100K round from Right Side Capital Management and gener8tor

Cryton Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cryton Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cryton Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersAustin, Minnesota
Year FoundedN/A
Last FundingAug 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?